| 2023 | Comparative effectiveness of JAK inhibitors and biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis | 이지수 | Article |
| 2017 | Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis | 이지수 | Article |
| 2014 | Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial | 이지수 | Article |
| 2023 | Enhanced intra-articular therapy for rheumatoid arthritis using click-crosslinked hyaluronic acid hydrogels loaded with toll-like receptor antagonizing peptides | 김한수 | Article |
| 2017 | Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis | 이지수 | Article |
| 2016 | Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study | 이지수 | Article |
| 2019 | Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study | 이지수 | Article |
| 2021 | Switching from TNFα inhibitor to tacrolimus as maintenance therapy in rheumatoid arthritis after achieving low disease activity with TNFα inhibitors and methotrexate: 24-week result from a non-randomized, prospective, active-controlled trial | 이지수 | Article |
| 2016 | The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis | 이지수 | Article |
| 2018 | Treat-to-target strategy for asian patients with early rheumatoid arthritis: Result of a multicenter trial in Korea | 이지수 | Article |
